Spero Therapeutics SPRO
NASDAQ SPRO
$1.18 -0.04 (-3.44%)
As of: Oct 21, 2026 · 2:43 PM EDT

Spero Therapeutics (SPRO) Total Current Liabilities (2016 - 2026)

Updated

Spero Therapeutics' Total Current Liabilities was $8.43 million in Q2 2026, down 43.6% from $14.95 million a year earlier but up 53.5% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Total Current Liabilities (2016 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Spero Therapeutics came in at $8.87 million, down 81.9% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of -9.2% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $49.07 million in FY2024 (+32.1%), $37.15 million in FY2023 (+71.6%), $21.65 million in FY2022 (+16.0%) and $18.67 million in FY2021 (+30.2%).
  • Quarterly Total Current Liabilities has moved between $5.49 million (Q1 2026) and $69.2 million (Q1 2022) over five years.
  • Compared with a year earlier, Total Current Liabilities has declined for six straight quarters, with an average decline of 31.4% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q1 2022 (growth of 289.6%); the worst was Q4 2025 (a decline of 81.9%).
  • Per Business Quant data, SPRO's Total Current Liabilities in the three quarters before Q2 2026 was $5.49 million (Q1 2026), $8.87 million (Q4 2025) and $13.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 54.90 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn 41.64 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 11.02 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn 32.65 Bn
10 Spero Therapeutics 68.34 Mn -127.44 Mn - 8.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.43 Mn
Mar 31, 2026 5.49 Mn
Dec 31, 2025 8.87 Mn
Sep 30, 2025 13.65 Mn
Jun 30, 2025 14.95 Mn
Mar 31, 2025 29.16 Mn
Dec 31, 2024 49.07 Mn
Sep 30, 2024 49.10 Mn
Jun 30, 2024 45.63 Mn
Mar 31, 2024 41.82 Mn
Dec 31, 2023 37.15 Mn
Sep 30, 2023 25.46 Mn
Jun 30, 2023 17.32 Mn
Mar 31, 2023 22.99 Mn
Dec 31, 2022 21.65 Mn
Sep 30, 2022 16.23 Mn
Jun 30, 2022 14.23 Mn
Mar 31, 2022 69.20 Mn
Dec 31, 2021 18.67 Mn
Sep 30, 2021 17.26 Mn
API Access

Spero Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SPRO&period=max&api_key=YOUR_API_KEY